Order Article Reprints

Torrent-Rodríguez A, Cascos E, Garcés VN, Pérez-López E, Baile-González M, Rodríguez CM, Cascón MJP, Luque M, Esquirol A, Calvo CM, et al. Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation. Cancers. 2025; 17(19):3128. https://doi.org/10.3390/cancers17193128

Torrent-Rodríguez, Arnau, Enric Cascos, Víctor Navarro Garcés, Estefanía Pérez-López, Mónica Baile-González, Carlos Martín Rodríguez, María Jesús Pascual Cascón, Marta Luque, Albert Esquirol, Carmen Martín Calvo, and et al. 2025. "Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation" Cancers 17, no. 19: 3128. https://doi.org/10.3390/cancers17193128

Torrent-Rodríguez, A., Cascos, E., Garcés, V. N., Pérez-López, E., Baile-González, M., Rodríguez, C. M., Cascón, M. J. P., Luque, M., Esquirol, A., Calvo, C. M., Peña-Muñoz, F., Fernando, I. H., Ormtegi, I. O., Marín, A. J. S., Fernández-Luis, S., Domínguez-García, J. J., Fernández, S. V., Lorenzo, J. L. L., de Sanmamed Girón, M. F., ... Salas, M. Q., on behalf of the GETH-TC. (2025). Safety of Post-Transplant Cyclophosphamide-Based Prophylaxis in AML Patients with Pre-Existing Cardiac Morbidity Undergoing Allogeneic Hematopoietic Cell Transplantation. Cancers, 17(19), 3128. https://doi.org/10.3390/cancers17193128